101 related articles for article (PubMed ID: 33578925)
1. Effective Prediction of Prostate Cancer Recurrence through the
Gu Y; Lin X; Kapoor A; Li T; Major P; Tang D
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498739
[TBL] [Abstract][Full Text] [Related]
2. IQGAP3 is relevant to prostate cancer: A detailed presentation of potential pathomechanisms.
Mei W; Dong Y; Gu Y; Kapoor A; Lin X; Su Y; Vega Neira S; Tang D
J Adv Res; 2023 Dec; 54():195-210. PubMed ID: 36681115
[TBL] [Abstract][Full Text] [Related]
3. Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity.
Wei Y; Zhang T; Wang B; Pan J; Jin S; Fang B; Gu W; Qin X; Dai B; Lin G; Gan H; Wu J; Ye D; Zhu Y
Mol Oncol; 2023 Oct; 17(10):2183-2199. PubMed ID: 37584393
[TBL] [Abstract][Full Text] [Related]
4. Aberrant activation of five embryonic stem cell-specific genes robustly predicts a high risk of relapse in breast cancers.
Jacquet E; Chuffart F; Vitte AL; Nika E; Mousseau M; Khochbin S; Rousseaux S; Bourova-Flin E
BMC Genomics; 2023 Aug; 24(1):463. PubMed ID: 37592220
[TBL] [Abstract][Full Text] [Related]
5. Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development.
Gu Y; Chow MJ; Kapoor A; Mei W; Jiang Y; Yan J; De Melo J; Seliman M; Yang H; Cutz JC; Bonert M; Major P; Tang D
Transl Oncol; 2018 Aug; 11(4):1012-1022. PubMed ID: 29966864
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer.
Chen TY; Mihalopoulos M; Zuluaga L; Rich J; Ganta T; Mehrazin R; Tsao CK; Tewari A; Gonzalez-Kozlova E; Badani K; Dogra N; Kyprianou N
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834162
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression of a Panel of Ten CNTN1-Associated Genes during Prostate Cancer Progression and the Predictive Properties of the Panel Towards Prostate Cancer Relapse.
Gu Y; Chow MJ; Kapoor A; Lin X; Mei W; Tang D
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33578925
[TBL] [Abstract][Full Text] [Related]
8. Construction of a set of novel and robust gene expression signatures predicting prostate cancer recurrence.
Jiang Y; Mei W; Gu Y; Lin X; He L; Zeng H; Wei F; Wan X; Yang H; Major P; Tang D
Mol Oncol; 2018 Sep; 12(9):1559-1578. PubMed ID: 30024105
[TBL] [Abstract][Full Text] [Related]
9. Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer.
Yan J; Ojo D; Kapoor A; Lin X; Pinthus JH; Aziz T; Bismar TA; Wei F; Wong N; De Melo J; Cutz JC; Major P; Wood G; Peng H; Tang D
Cancer Res; 2016 Mar; 76(6):1603-14. PubMed ID: 26795349
[TBL] [Abstract][Full Text] [Related]
10. Contactin 1: An Important and Emerging Oncogenic Protein Promoting Cancer Progression and Metastasis.
Gu Y; Li T; Kapoor A; Major P; Tang D
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32752094
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of
Yang CA; Huang HY; Yen JC; Chang JG
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29843367
[TBL] [Abstract][Full Text] [Related]
12. miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence.
Jiao L; Deng Z; Xu C; Yu Y; Li Y; Yang C; Chen J; Liu Z; Huang G; Li LC; Sun Y
J Cell Physiol; 2014 Jul; 229(7):834-44. PubMed ID: 24243035
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
